Amplitech Group, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) covers events occurring on July 9, 2014, for Amplitech Group, Inc., a Nevada corporation. The filing details a material definitive agreement for equity financing and a corporate governance amendment regarding authorized share capital.
Key Financial Metrics and Capital Structure
- Capital Raise: Entered into a Securities Purchase Agreement to sell 13,000,000 shares of common stock for a total purchase price of $300,000.
- Transaction Structure: The sale is structured in three equal installments of 4,333,333 shares for $100,000 each.
- Share Price: Effective price of approximately $0.023 per share.
- Use of Proceeds: General working capital and $40,000 specifically allocated to pay down debt owed to JMJ Financial.
- Authorized Capital: Increased authorized common stock to 500,000,000 shares (par value $0.001); preferred stock remains at 500,000 shares.
Material Changes and Transaction Details
The primary material change is the execution of the agreement with Microphase Corporation. The first tranche of 4,333,333 shares was consummated on July 10, 2014. Subsequent tranches are scheduled for August 15, 2014, and September 15, 2014. The securities were sold under Section 4(2) of the Securities Act of 1933 to an accredited investor.
Outlook, Risks, and Anti-Dilution Provisions
- Anti-Dilution Protection: Microphase holds a full ratchet anti-dilution provision for two years or until they hold no shares. This applies if the Company issues stock or convertible securities at a price of $0.023 per share or less.
- Debt Reduction: Immediate reduction of specific debt obligations to JMJ Financial using initial proceeds.
- Management Commentary: The filing does not provide forward-looking guidance, revenue projections, or management commentary beyond the transaction mechanics.
Investor Verification Checklist
- Verify the status of the debt owed to JMJ Financial and confirm the $40,000 payment was executed.
- Confirm the completion of the second and third tranches of the stock sale on August 15 and September 15, 2014.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific exceptions to the full ratchet anti-dilution provision.
- Assess the impact of the 13,000,000 new shares on existing shareholder dilution.
- Note that this filing does not contain audited financial statements, revenue data, or cash flow metrics; refer to the most recent 10-K or 10-Q for those figures.